Elsevier Inc.

SHERPA: Unknown

People

  1. Riely
    Riely
  2. Chaft
    Chaft
  3. Kris
    Kris
  4. D'Angelo
    D'Angelo
  5. Janjigian
    Janjigian
  6. Ladanyi
    Ladanyi
  7. Miller
    Miller
  8. Rekhtman
    Rekhtman
  9. Rusch
    Rusch
  10. Shen
    Shen

Groups

  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Thoracic Oncology (5)
  4. GSK Faculty (2)
  5. Human Oncology and Pathogenesis Program (2)
  6. Tow Center for Developmental Oncology (TCDO) (2)
  7. Biostatistics Service (1)
  8. Epidemiology and Biostatistics (1)
  9. Gastrointestinal Oncology Service (1)
  10. Hematologic Malignancies, Division of (1)
Search Within
  1. "Gregory Riely"
  2. "2012"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Thoracic Oncology (5)
  4. GSK Faculty (2)
  5. Human Oncology and Pathogenesis Program (2)
  6. Tow Center for Developmental Oncology (TCDO) (2)

More Groups

People
  1. Gregory Riely (5)
  2. Christopher Azzoli (2)
  3. Jamie Chaft (2)
  4. Marc Ladanyi (2)
  5. Mark Kris (2)
  6. Camelia Sima (1)

More People

Years
  1. 2012 (5)
Publications
  1. Journal of Thoracic Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Riely, G. J.; Evans, T. L.; Salgia, R.; Ou, S. I.; Gettinger, S. N.; Otterson, G. A.; Lanzalone, S.; Polli, A.; Shaw, A. T.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
    Journal Article

    D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Efficacy and safety of crizotinib in advanced alk-positive non-small cell lung cancer (NSCLC) results from a phase II global trial
    Meeting Abstract

    Ferreira, C. G.; Barrios, C.; Shaw, A. T.; Shi, Y. K.; De Pas, T. M.; Yang, P. C.; Riely, G. J.; Crino, L.; Iyer, S.; Polli, A.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Gadgeel, S. M.; Dowlati, A.; Lynch, T. J.; Salgia, R.; Rowland, K. M. Jr; Wertheim, M. S.; Price, K. A.; Riely, G. J.; Azzoli, C. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • ALK-rearranged lung cancer: Adenosquamous lung cancer masquerading as pure squamous carcinoma
    Journal Article

    Chaft, J. E.; Rekhtman, N.; Ladanyi, M.; Riely, G. J.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save